Nonclassical monocytes: are they the next therapeutic targets in multiple sclerosis?

Immunol Cell Biol. 2018 Feb;96(2):125-127. doi: 10.1111/imcb.12004. Epub 2018 Jan 20.

Authors

Bahareh Ajami¹, Lawrence Steinman¹

Affiliation

¹ Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA, 94305, USA.

PMID: 29352485
DOI: 10.1111/imcb.12004

No abstract available

Publication types

Comment

MeSH terms

Flow Cytometry
Humans
Monocytes*
Multiple Sclerosis*